GlaxoSmithKline to sell non-core products: report | Reuters

(Reuters) - GlaxoSmithKline (GSK.L

) has taken a group of private equity funds and strategic bidders through to a second round of the sale of its non-core over-the-counter products, the Financial Times reported on Friday.

The sale is estimated to be worth 1.5 billion pounds ($2.4 billion).

The newspaper cited people familiar with the situation as saying that U.S. buyout funds Bain Capital, Blackstone (BX.N) and German pharmaceutical group Boehringer Ingelheim were still in the bidding process.

via uk.reuters.com

Posted via email from Jack's posterous